创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: The Unique Advantages of the ELISpot Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-15 13:55
  • Views:

(Summary description)With the rapid development of life sciences, there is a growing demand for efficient and accurate research tools. Against this backdrop, InnoModels Biotechnology has successfully provided strong support to the research field with its leading ELISpot technology

InnoModels Biotechnology: The Unique Advantages of the ELISpot Platform

(Summary description)With the rapid development of life sciences, there is a growing demand for efficient and accurate research tools. Against this backdrop, InnoModels Biotechnology has successfully provided strong support to the research field with its leading ELISpot technology

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-15 13:55
  • Views:
Information

With the rapid development of life sciences, there is a growing demand for efficient and accurate research tools. Against this backdrop, InnoModels Biotechnology has successfully provided strong support to the research field with its leading ELISpot technology.
First of all, InnoModels' ELISpot platform has won the trust of users with its excellent performance and stability. Through a unique detection principle, ELISpot technology enables precise detection of individual cell-secreted proteins, providing in-depth understanding of cell function, immune response and other key information. InnoModels Biotechnology continuously optimizes its ELISpot platform to ensure that it performs well under various experimental conditions, bringing users reliable results.
Secondly, InnoModels Biotechnology emphasizes the needs of its customers and is committed to providing comprehensive training and technical support. Through online training, seminars, and a professional technical support team, InnoModels Biotechnology ensures that users are able to fully understand and correctly apply the ELISpot technology to maximize its benefits. This comprehensive service not only improves the efficiency of users' experiments, but also promotes the wide application of ELISpot technology in the field of scientific research.

 


In addition, InnoModels Biotechnology continues to invest in research and development in the field of ELISpot technology, launching new products and technological innovations. Through close collaboration with academic and industrial partners, InnoModels Biotechnology remains at the forefront of technology to meet the constant demand for efficient and reliable immunoassay tools in the research field. This spirit of innovation not only drives the company's own development, but also brings more possibilities to the entire research field.
Last but not least, InnoModels Biotechnology always focuses on customers and continuously optimizes its products and services. Whether it is the selection of experimental reagents, instruments and equipment, or the design of the experimental process, InnoModels Biotechnology always takes into full consideration the actual needs of its customers to ensure that it provides the best experimental experience for its users. This customer-oriented business philosophy makes InnoModels Biotechnology stand out in the highly competitive research reagent market.
In conclusion, the ELISpot platform of InnoModels Biotechnology has become a leader in the scientific research field due to its excellent performance, comprehensive training and technical support, continuous innovation and customer-oriented business philosophy. In the future, InnoModels Biotechnology will continue to be committed to promoting the development of ELISpot technology and bringing more innovations and breakthroughs to the research field. We look forward to working with more researchers to explore the mysteries of life science.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司